{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:50:34Z","timestamp":1794585034979,"version":"4.9.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12883-019-1437-9","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T09:05:02Z","timestamp":1567069502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Bismuth encephalopathy- a rare complication of long-standing use of bismuth subsalicylate"],"prefix":"10.1186","volume":"19","author":[{"given":"Cl\u00e1udia","family":"Borbinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipa","family":"Serrazina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Salavisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Viana-Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,29]]},"reference":[{"issue":"9","key":"1437_CR1","doi-asserted-by":"publisher","first-page":"15258","DOI":"10.3390\/molecules190915258","volume":"19","author":"DM Keogan","year":"2014","unstructured":"Keogan DM, Griffith DM. Current and potential applications of bismuth-based drugs. Molecules. 2014;19(9):15258\u201397.","journal-title":"Molecules."},{"issue":"18","key":"1437_CR2","first-page":"912","volume":"1","author":"AW Morrow","year":"1973","unstructured":"Morrow AW. Request for reports: adverse reactions with bismuth subgallate. Med J Australia. 1973;1(18):912.","journal-title":"Med J Australia."},{"key":"1437_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/bmj.1.5901.220","volume":"1","author":"R Burns","year":"1974","unstructured":"Burns R, Thomas DW, Barrow VJ. Reversible encephalopathy possibly associated with bismuth subgallate ingestion. Br Med J. 1974;1:220\u20133.","journal-title":"Br Med J"},{"issue":"2","key":"1437_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.2042-7174.1993.tb00737.x","volume":"2","author":"CK Ching","year":"1993","unstructured":"Ching CK, Long RG, O\u2019Hara R, et al. Iatrogenic bismuth toxicity associated with inadvertent long term De-Noltab ingestion. Int J Pharm Pract. 1993;2(2):111\u20133.","journal-title":"Int J Pharm Pract"},{"issue":"6","key":"1437_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/NRL.0000000000000144","volume":"22","author":"P Sampognaro","year":"2017","unstructured":"Sampognaro P, Vo KT, Richie M, Blanc PD, Keenan K. Bismuth Subgallate toxicity in the age of online supplement use. Neurologist. 2017;22(6):237\u201340.","journal-title":"Neurologist."},{"issue":"4","key":"1437_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.5770\/cgj.21.323","volume":"21","author":"David B. Hogan","year":"2018","unstructured":"Hogan DB, Harbidge C, Duncan A. Bismuth toxicity presenting as declining mobility and falls. Canadian Geriatrics Journal. 2018;21(4).","journal-title":"Canadian Geriatrics Journal"},{"issue":"2","key":"1437_CR7","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1212\/WNL.0000000000004093","volume":"89","author":"Farwa Ali","year":"2017","unstructured":"Ali F, Murray JA, Adams AC, Flanagan EP. Clinical reasoning: a 54-year-old woman with dementia, myoclonus, and ataxia. Neurology. 2017;89(2).","journal-title":"Neurology"},{"issue":"3","key":"1437_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10072-018-3634-5","volume":"40","author":"A Brigand\u00ec","year":"2019","unstructured":"Brigand\u00ec A, Rizzo V, Ziccone V, Girlanda P. Bismuth-related acute neurotoxicity as stroke mimic: a case report. Neurol Sci. 2019;40(3):653\u20134.","journal-title":"Neurol Sci"},{"issue":"3","key":"1437_CR9","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/0016-5085(90)90983-8","volume":"99","author":"SL Gorbach","year":"1990","unstructured":"Gorbach SL. Bismuth therapy in gastrointestinal diseases. Gastroenterol. 1990;99(3):863\u201375.","journal-title":"Gastroenterol."},{"key":"1437_CR10","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1093\/clinids\/12.Supplement_1.S64","volume":"12","author":"HL DuPont","year":"1990","unstructured":"DuPont HL, Ericsson CD, Johnson PC, de la Cabada FJ. Use of bismuth subsalicylate for the prevention of travelers\u2019 diarrhea. Rev Infect Dis. 1990;12:S64\u20137.","journal-title":"Rev Infect Dis"},{"issue":"11","key":"1437_CR11","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3109\/00099308109035067","volume":"18","author":"G Martin-Bouyer","year":"1981","unstructured":"Martin-Bouyer G, Foulon G, Guerbois H, Barin C. Epidemiological study of encephalopathies following bismuth administration per os. Characteristics of intoxicated subjects: comparison with a control group. Clin Toxicol. 1981;18(11):1277\u201383.","journal-title":"Clin Toxicol"},{"issue":"Supplement_1","key":"1437_CR12","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/clinids\/12.Supplement_1.S3","volume":"12","author":"Douglas Ws. Bierer","year":"1990","unstructured":"Bierer DW. Bismuth subsalicylate: history, chemistry, and safety. Rev Infect Dis. 1990;12 Suppl 1:S3-8.","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"1437_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jnnp.44.1.1","volume":"44","author":"PM Le Quesne","year":"1981","unstructured":"Le Quesne PM. Toxic substances and the nervous system: the role of clinical observation. J Neurol Neurosurg Psychiatry. 1981;44(1):1\u20138 Review.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"14","key":"1437_CR14","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1212\/WNL.0000000000007236","volume":"92","author":"V Saini","year":"2019","unstructured":"Saini V, Chalfin R, Leon J, Margolesky J. Pearls & oy-sters: bismuth neurotoxicity from use of topical bismuth dressing for burns. Neurology. 2019;92(14):680\u20131.","journal-title":"Neurology."},{"issue":"4","key":"1437_CR15","doi-asserted-by":"publisher","first-page":"167","DOI":"10.5694\/j.1326-5377.1982.tb124313.x","volume":"2","author":"GJ Hasking","year":"1982","unstructured":"Hasking GJ, Duggan JM. Encephalopathy from bismuth subsalicylate. Med J Australia. 1982;2(4):167.","journal-title":"Med J Australia"},{"issue":"2","key":"1437_CR16","doi-asserted-by":"publisher","first-page":"140","DOI":"10.7326\/0003-4819-112-2-140","volume":"112","author":"PC Mendelowitz","year":"1990","unstructured":"Mendelowitz PC, Hoffman RS, Weber S. Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy. Ann Intern Med. 1990;112(2):140\u20131.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1437_CR17","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1212\/WNL.43.6.1265","volume":"43","author":"AC Jungreis","year":"1993","unstructured":"Jungreis AC, Schaumburg HH. Encephalopathy from abuse of bismuth subsalicylate (Pepto-Bismol). Neurol. 1993;43(6):1265.","journal-title":"Neurol."},{"issue":"2","key":"1437_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/mds.870100215","volume":"10","author":"MF Gordon","year":"1995","unstructured":"Gordon MF, Abrams RI, Rubin DB, et al. Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus. Mov Disord. 1995;10(2):220\u20132.","journal-title":"Mov Disord"},{"key":"1437_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.4236\/ijcm.2012.31010","volume":"3","author":"PT Reynolds","year":"2012","unstructured":"Reynolds PT, Abalos KC, Hopp J, et al. Bismuth toxicity: a rare cause of neurological dysfunction. Int J Clin Med. 2012;3:46\u20138.","journal-title":"Int J Clin Med"},{"issue":"3","key":"1437_CR20","first-page":"32","volume":"109","author":"Y Masannat","year":"2013","unstructured":"Masannat Y, Nazer E. Pepto bismuth associated neurotoxicity: a rare side effect of a commonly used medication. West Virginia Med J. 2013;109(3):32\u20134.","journal-title":"West Virginia Med J"},{"issue":"1","key":"1437_CR21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/0028-3886.198185","volume":"65","author":"R Siram","year":"2017","unstructured":"Siram R, Botta R, Kashikunte C, et al. Chronic encephalopathy with ataxia, myoclonus, and auditory neuropathy: a case of bismuth poisoning. Neurol India. 2017;65(1):186\u20137.","journal-title":"Neurol India"},{"issue":"39","key":"1437_CR22","doi-asserted-by":"publisher","first-page":"14126","DOI":"10.3748\/wjg.v20.i39.14126","volume":"20","author":"HY Qin","year":"2014","unstructured":"Qin HY, Cheng CW, Tang XD, Bian ZX. Impact of psychological stress on irritable bowel syndrome. World J Gastroenterol. 2014;20(39):14126\u201331.","journal-title":"World J Gastroenterol"},{"key":"1437_CR23","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1136\/jnnp.40.8.748","volume":"40","author":"V Supino-Viterbo","year":"1977","unstructured":"Supino-Viterbo V, Sicard C, Risvegliato M, Rancurel G, Buge A. Toxic encephalopathy due to ingestion of bismuth salts: clinical and EEG studies of 45 patients. J Neurol Neurosurg Psychiatry. 1977;40:748\u201352.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"1437_CR24","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1007\/s00467-005-1993-7","volume":"20","author":"N Cengiz","year":"2005","unstructured":"Cengiz N, Uslu Y, G\u00f6k F, Anarat A. Acute renal failure after overdose of colloidal bismuth subcitrate. Pediatr Nephrol. 2005;20(9):1355\u20138.","journal-title":"Pediatr Nephrol"},{"key":"1437_CR25","first-page":"288","volume-title":"Oral and maxillofacial pathology","author":"BW Neville","year":"2015","unstructured":"Neville BW, Damm DD, Allen CM, Chi AC. Physical and chemical injuries. In: Oral and maxillofacial pathology. 4th ed. St. Louis: Elsevier Health Sciences; 2015. p. 288\u20139.","edition":"4"},{"issue":"1","key":"1437_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1136\/jnnp.44.1.62","volume":"44","author":"A Buge","year":"1981","unstructured":"Buge A, Supino-Viterbo V, Rancurel G, Pontes C. Epileptic phenomena in bismuth toxic encephalopathy. J Neurol Neurosurg Psychiatry. 1981;44(1):62\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1437_CR27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1684\/j.1950-6945.2002.tb00499.x","volume":"4","author":"M Teepker","year":"2002","unstructured":"Teepker M, Hamer HM, Knake S, Bandmann O, Oertel WH, Rosenow F. Myoclonic encephalopathy caused by chronic bismuth abuse. Epileptic Disorders. 2002;4:229\u201333.","journal-title":"Epileptic Disorders"},{"issue":"9","key":"1437_CR28","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1080\/15563650801953182","volume":"46","author":"H Ovaska","year":"2008","unstructured":"Ovaska H, Wood DM, House I, Dargan PI, Jones AL, Murray S. Severe iatrogenic bismuth poisoning with BIsmuth Iodoform paraffin paste treated with DMPS chelation. Clin Toxicol. 2008;46(9):855\u20137.","journal-title":"Clin Toxicol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1437-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-019-1437-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-019-1437-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T18:39:07Z","timestamp":1721673547000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-019-1437-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,29]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1437"],"URL":"https:\/\/doi.org\/10.1186\/s12883-019-1437-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,29]]},"assertion":[{"value":"13 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the consent is available for review by the editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}